CRISPR Therapeutics Announces the Appointment of Jon Terrett, Ph.D. to Head of Immuno-Oncology Research and … – Yahoo Finance
Genetic Literacy Project |
CRISPR Therapeutics Announces the Appointment of Jon Terrett, Ph.D. to Head of Immuno-Oncology Research and …
Yahoo Finance “We are thrilled to have Dr. Terrett join CRISPR to head up our immuno-oncology efforts,” commented Rodger Novak, CEO of CRISPR Therapeutics. “Given the potential of CRISPR/Cas9 gene editing in immuno-oncology, we have created a dedicated unit to … Who should own revolutionary gene editor CRISPR? Scientists or the public? Important decision from the USPTO in the field of genome engineering |
